{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:05:44Z","timestamp":1783904744467,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-026-00455-x","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:45:08Z","timestamp":1779198308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GMP-compliant automated synthesis and quality control of [177Lu]Lu-PSMA-I&amp;T using the GAIA\/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer"],"prefix":"10.1186","volume":"11","author":[{"given":"Am\u00e9lie","family":"Coussirou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Six","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Edet-Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tonnelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-9022","authenticated-orcid":false,"given":"Pierre","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","DOI":"10.15392\/2319-0612.2024.2690","volume":"12","author":"LM Balieiro","year":"2024","unstructured":"Balieiro LM, Domingos MD, Da Silva LP, Dos Santos JM, Matsuda MMN, Dias LAP, et al. Optimization of PSMA-I&T radiolabeling with 177Lu. Braz J Radiat Sci. 2024;12:e2690.","journal-title":"Braz J Radiat Sci"},{"key":"455_CR2","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","volume":"82","author":"DG Bostwick","year":"1998","unstructured":"Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer. 1998;82:2256\u201361.","journal-title":"Cancer"},{"key":"455_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-023-00196-1","volume":"8","author":"A Cankaya","year":"2023","unstructured":"Cankaya A, Balzer M, Amthauer H, Brenner W, Spreckelmeyer S. Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application. EJNMMI Radiopharm Chem. 2023;8:10.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"455_CR4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70020","author":"D Chakrabarti","year":"2025","unstructured":"Chakrabarti D, Albertsen P, Adkins A, Kishan A, Murthy V, Parker C, et al. The contemporary management of prostate cancer. CA Cancer J Clin. 2025. https:\/\/doi.org\/10.3322\/caac.70020.","journal-title":"CA Cancer J Clin"},{"key":"455_CR5","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.3390\/molecules27134143","volume":"27","author":"V Di Iorio","year":"2022","unstructured":"Di Iorio V, Boschi S, Cuni C, Monti M, Severi S, Paganelli G, et al. Production and quality control of [177Lu]Lu-PSMA-I&T: development of an investigational medicinal product dossier for clinical trials. Molecules. 2022;27:4143.","journal-title":"Molecules"},{"key":"455_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2022.990330","volume":"2","author":"A Faivre-Chauvet","year":"2022","unstructured":"Faivre-Chauvet A, Bourdeau C, Bourgeois M. Radiopharmaceutical good practices: regulation between hospital and industry. Front Nucl Med. 2022;2:990330.","journal-title":"Front Nucl Med"},{"key":"455_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-021-00123-2","volume":"6","author":"N Gillings","year":"2021","unstructured":"Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, et al. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6:8.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"455_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41181-025-00372-5","volume":"10","author":"W Hunt","year":"2025","unstructured":"Hunt W, Long M, Kamil U, Kellapatha S, Noonan W, Roselt PD, et al. Multifactorial analysis of radiochemical purity in high-activity 177Lu-labeled theranostics: impact of precursor source, 177Lu form, and production parameters. EJNMMI Radiopharm Chem. 2025;10:47.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"455_CR9","first-page":"1807","volume":"54","author":"RS Israeli","year":"1994","unstructured":"Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD. Expression of the prostate-specific membrane antigen. Cancer Res. 1994;54:1807\u201311.","journal-title":"Cancer Res"},{"issue":"1","key":"455_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-023-00191-6","volume":"8","author":"M Kraihammer","year":"2023","unstructured":"Kraihammer M, Garnuszek P, Bauman A, Maurin M, Lafont MA, Haubner R, et al. Improved quality control of [177Lu]Lu-PSMA I&T. EJNMMI Radiopharm Chem. 2023;8(1):7.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"455_CR11","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1021\/acs.jmedchem.1c00045","volume":"64","author":"S Martin","year":"2021","unstructured":"Martin S, T\u00f6nnesmann R, Hierlmeier I, Maus S, Rosar F, Ruf J, et al. Identification, characterization, and suppression of side products formed during the synthesis of [177Lu]Lu-PSMA-617. J Med Chem. 2021;64:4960\u201371.","journal-title":"J Med Chem"},{"key":"455_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050522","volume":"15","author":"P Orhon","year":"2022","unstructured":"Orhon P, Desruet MD, Piquemal M, De Leiris N, Djaileb L, Vuillez JP, et al. Development and validation of analytical methods for radiochemical purity of 177Lu-PSMA-1. Pharmaceuticals (Basel). 2022;15:522.","journal-title":"Pharmaceuticals (Basel)"},{"key":"455_CR13","first-page":"6357","volume":"9","author":"JS Ross","year":"2003","unstructured":"Ross JS, Sheehan CE, Fisher HA, Kaufman RP, Kaur P, Gray K, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res. 2003;9:6357\u201362.","journal-title":"Clin Cancer Res"},{"key":"455_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28237696","volume":"28","author":"S Schmitl","year":"2023","unstructured":"Schmitl S, Raitanen J, Witoszynskyj S, Patronas EM, Nics L, Ozenil M, et al. Quality assurance investigations and impurity characterization during upscaling of [177Lu]Lu-PSMAI&T. Molecules. 2023;28:7696.","journal-title":"Molecules"},{"key":"455_CR15","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3:81\u20135.","journal-title":"Clin Cancer Res"},{"key":"455_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jlcr.3846","volume":"63","author":"MA S\u00f8rensen","year":"2020","unstructured":"S\u00f8rensen MA, Andersen VL, Hendel HW, Vriamont C, Warnier C, Masset J, et al. Automated synthesis of 68Ga\/177Lu-PSMA on the trasis miniAllinOne. J Labelled Comp Radiopharm. 2020;63:393\u2013403.","journal-title":"J Labelled Comp Radiopharm"},{"key":"455_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2967\/jnmt.121.262423","volume":"50","author":"M Vyas","year":"2022","unstructured":"Vyas M, Lim R, Fagan J, Chandrashekar R. Stability matters: radiochemical stability of therapeutic radiopharmaceutical 177Lu-PSMA I&T. J Nucl Med Technol. 2022;50:244\u20137.","journal-title":"J Nucl Med Technol"},{"key":"455_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eururo.2024.04.036","volume":"86","author":"P Vynckier","year":"2024","unstructured":"Vynckier P, Annemans L, Raes S, Amrouch C, Lindgren P, M\u00e1jek O, et al. Systematic review on the cost effectiveness of prostate cancer screening in Europe. Eur Urol. 2024;86:400\u20138.","journal-title":"Eur Urol"},{"key":"455_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","volume":"56","author":"M Weineisen","year":"2015","unstructured":"Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, et al. 68Ga- and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies. J Nucl Med. 2015;56:1169\u201376.","journal-title":"J Nucl Med"},{"key":"455_CR20","first-page":"493","volume-title":"Handbook for chemical process research and development","author":"W Zhao","year":"2023","unstructured":"Zhao W. Telescope approach. In: Zhao W, editor. Handbook for chemical process research and development. Boca Raton: CRC Press; 2023. p. 493\u2013526."}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-026-00455-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:12:18Z","timestamp":1783901538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-026-00455-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1186\/s41181-026-00455-x","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients included in this study provided written consent for the use of their health data for research purposes. They were informed that they had received a drug under compassionate access.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}